Since the FDA approved Wegovy in 2021 and Zepbound in 2023, public awareness of GLP-1 drugs have surged
With a firm commitment to scientifically validated impact reduction, innovative material use and seamless supply chain integration, Ypsomed is empowering pharmaceutical companies to make meaningful strides toward greener drug administration
Renal and hepatic function
Probiotics, Psychobiotics, and Microbiota Transfer Therapy Once we understand the depth of the dysbiosis problem in autism, the question becomes: how do we restore a healthy microbial ecosystem
These serious adverse events underscore why IV glutathione should only be used in controlled medical settings for approved indications, not for cosmetic purposes
Tirzepatide vs Semaglutide A 2025 NEJM study found: Tirzepatide: 20.2% loss Semaglutide 2.4 mg: 13.7% loss Tirzepatide produced 47% greater relative weight loss Source: Aronne et al., 2025